China Pharma Holdings Current Ratio 2006-2019 | CPHI

China Pharma Holdings current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
China Pharma Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.01B $0.01B 0.89
2018-12-31 $0.01B $0.01B 0.87
2018-09-30 $0.01B $0.01B 0.99
2018-06-30 $0.01B $0.01B 1.35
2018-03-31 $0.01B $0.01B 1.40
2017-12-31 $0.01B $0.01B 1.33
2017-09-30 $0.02B $0.01B 1.44
2017-06-30 $0.02B $0.01B 1.64
2017-03-31 $0.02B $0.01B 1.66
2016-12-31 $0.02B $0.01B 1.69
2016-09-30 $0.02B $0.01B 1.62
2016-06-30 $0.02B $0.01B 1.69
2016-03-31 $0.03B $0.01B 1.79
2015-12-31 $0.02B $0.01B 1.90
2015-09-30 $0.04B $0.02B 2.24
2015-06-30 $0.04B $0.01B 3.07
2015-03-31 $0.04B $0.02B 2.79
2014-12-31 $0.04B $0.01B 2.96
2014-09-30 $0.06B $0.01B 4.46
2014-06-30 $0.07B $0.01B 5.81
2014-03-31 $0.08B $0.01B 6.64
2013-12-31 $0.08B $0.01B 6.99
2013-09-30 $0.10B $0.01B 7.59
2013-06-30 $0.10B $0.02B 6.97
2013-03-31 $0.11B $0.01B 8.57
2012-12-31 $0.11B $0.02B 7.69
2012-09-30 $0.12B $0.02B 7.18
2012-06-30 $0.12B $0.02B 7.13
2012-03-31 $0.12B $0.02B 6.78
2011-12-31 $0.11B $0.01B 8.03
2011-09-30 $0.11B $0.01B 8.04
2011-06-30 $0.10B $0.01B 8.19
2011-03-31 $0.10B $0.01B 7.62
2010-12-31 $0.09B $0.01B 7.18
2010-09-30 $0.09B $0.01B 7.73
2010-06-30 $0.08B $0.01B 6.47
2010-03-31 $0.08B $0.01B 7.06
2009-12-31 $0.07B $0.01B 6.79
2009-09-30 $0.07B $0.01B 6.93
2009-06-30 $0.06B $0.01B 8.08
2009-03-31 $0.06B $0.01B 9.32
2008-12-31 $0.06B $0.01B 10.73
2008-09-30 $0.06B $0.00B 23.65
2008-06-30 $0.06B $0.01B 11.34
2008-03-31 $0.04B $0.01B 8.90
2007-12-31 $0.04B $0.00B 9.77
2007-09-30 $0.04B $0.01B 4.66
2007-06-30 $0.04B $0.01B 4.47
2007-03-31 $0.03B $0.01B 4.06
2006-12-31 $0.03B $0.01B 3.37
2006-09-30 $0.02B $0.01B 2.69
2006-06-30 $0.02B $0.01B 2.94
2006-03-31 $0.02B $0.01B 2.51
2005-12-31 $0.01B $0.01B 2.51
2005-09-30 $0.12B $0.11B 1.11
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.012B $0.012B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $37.937B 6.91
Mylan (MYL) United Kingdom $8.902B 3.89
Teva Pharmaceutical Industries (TEVA) Israel $8.338B 3.27
Bausch Health Cos (BHC) Canada $7.741B 5.29
Dr Reddy's Laboratories (RDY) India $6.019B 22.52
Supernus Pharmaceuticals (SUPN) United States $1.573B 15.72
Voyager Therapeutics (VYGR) United States $0.985B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.954B 53.34
Homology Medicines (FIXX) United States $0.834B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.755B 1.13
Akorn (AKRX) United States $0.546B 0.00
CymaBay Therapeutics (CBAY) United States $0.451B 0.00
Assembly Biosciences (ASMB) United States $0.383B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.370B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.283B 0.00
Sol-Gel Technologies (SLGL) Israel $0.162B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.131B 0.00
Acasti Pharma (ACST) Canada $0.072B 0.00
Agile Therapeutics (AGRX) United States $0.061B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Teligent (TLGT) United States $0.023B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.012B 0.00